Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Aug 1;102(3):584–594. doi: 10.1172/JCI2329

Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia.

M E Sunday 1, B A Yoder 1, F Cuttitta 1, K J Haley 1, R L Emanuel 1
PMCID: PMC508919  PMID: 9691095

Abstract

The etiology of bronchopulmonary dysplasia (BPD), a chronic lung disease of infants surviving respiratory distress syndrome, remains fundamentally enigmatic. BPD is decreasing in severity but continues to be a major problem in pediatric medicine, being especially prevalent among very premature infants. Increased numbers of pulmonary neuroendocrine cells containing bombesin-like peptide (BLP) have been reported to occur in human infants with BPD. We tested the hypothesis that BLP mediates BPD using the hyperoxic baboon model. Urine BLP levels increased soon after birth only in 100% O2-treated 140-d animals which developed BPD, correlating closely with severity of subsequent chronic lung disease. Similar elevations in urine BLP were observed in the 125-d baboon "interrupted gestation" model of BPD. Postnatal administration of anti-BLP antibody attenuated clinical and pathological evidence of chronic lung disease in the hyperoxic baboon model. Urine BLP could be a biological predictor of infants at risk for BPD, and blocking BLP postnatally could be useful for BPD prevention.

Full Text

The Full Text of this article is available as a PDF (871.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abman S. H., Groothius J. R. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr Clin North Am. 1994 Apr;41(2):277–315. doi: 10.1016/s0031-3955(16)38726-0. [DOI] [PubMed] [Google Scholar]
  2. Asokananthan N., Cake M. H. Stimulation of surfactant lipid secretion from fetal type II pneumocytes by gastrin-releasing peptide. Am J Physiol. 1996 Mar;270(3 Pt 1):L331–L337. doi: 10.1152/ajplung.1996.270.3.L331. [DOI] [PubMed] [Google Scholar]
  3. Avery M. E., Tooley W. H., Keller J. B., Hurd S. S., Bryan M. H., Cotton R. B., Epstein M. F., Fitzhardinge P. M., Hansen C. B., Hansen T. N. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987 Jan;79(1):26–30. [PubMed] [Google Scholar]
  4. Avis I. L., Kovacs T. O., Kasprzyk P. G., Treston A. M., Bartholomew R., Walsh J. H., Cuttitta F., Mulshine J. L. Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer. J Natl Cancer Inst. 1991 Oct 16;83(20):1470–1476. doi: 10.1093/jnci/83.20.1470. [DOI] [PubMed] [Google Scholar]
  5. Bousbaa H., Poron F., Fleury-Feith J. Changes in chromogranin A-immunoreactive guinea-pig pulmonary neuroendocrine cells after sensitization and challenge with ovalbumin. Cell Tissue Res. 1994 Jan;275(1):195–199. doi: 10.1007/BF00305387. [DOI] [PubMed] [Google Scholar]
  6. Coalson J. J., Kuehl T. J., Escobedo M. B., Hilliard J. L., Smith F., Meredith K., Null D. M., Jr, Walsh W., Johnson D., Robotham J. L. A baboon model of bronchopulmonary dysplasia. II. Pathologic features. Exp Mol Pathol. 1982 Dec;37(3):335–350. doi: 10.1016/0014-4800(82)90046-6. [DOI] [PubMed] [Google Scholar]
  7. Coalson J. J., Winter V. T., Gerstmann D. R., Idell S., King R. J., Delemos R. A. Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):872–881. doi: 10.1164/ajrccm/145.4_Pt_1.872. [DOI] [PubMed] [Google Scholar]
  8. DeLemos R., Wolfsdorf J., Nachman R., Block A. J., Leiby G., Wilkinson H. A., Allen T., Haller J. A., Morgan W., Avery M. E. Lung injury from oxygen in lambs: the role of artificial ventilation. Anesthesiology. 1969 Jun;30(6):609–618. doi: 10.1097/00000542-196906000-00007. [DOI] [PubMed] [Google Scholar]
  9. Escobedo M. B., Hilliard J. L., Smith F., Meredith K., Walsh W., Johnson D., Coalson J. J., Kuehl T. J., Null D. M., Jr, Robotham J. L. A baboon model of bronchopulmonary dysplasia. I. Clinical features. Exp Mol Pathol. 1982 Dec;37(3):323–334. doi: 10.1016/0014-4800(82)90045-4. [DOI] [PubMed] [Google Scholar]
  10. Floros J., Nielsen H. C., Torday J. S. Dihydrotestosterone blocks fetal lung fibroblast-pneumonocyte factor at a pretranslational level. J Biol Chem. 1987 Oct 5;262(28):13592–13598. [PubMed] [Google Scholar]
  11. Fraslon C., Bourbon J. R. Comparison of effects of epidermal and insulin-like growth factors, gastrin releasing peptide and retinoic acid on fetal lung cell growth and maturation in vitro. Biochim Biophys Acta. 1992 Jan 3;1123(1):65–75. doi: 10.1016/0005-2760(92)90172-r. [DOI] [PubMed] [Google Scholar]
  12. Goetzman B. W., Read L. C., Plopper C. G., Tarantal A. F., George-Nascimento C., Merritt T. A., Whitsett J. A., Styne D. Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants. Pediatr Res. 1994 Jan;35(1):30–36. doi: 10.1203/00006450-199401000-00008. [DOI] [PubMed] [Google Scholar]
  13. Haley K. J., Drazen J. M., Osathanondh R., Sunday M. E. Comparison of the ontogeny of protein gene product 9.5, chromogranin A and proliferating cell nuclear antigen in developing human lung. Microsc Res Tech. 1997 Apr 1;37(1):62–68. doi: 10.1002/(SICI)1097-0029(19970401)37:1<62::AID-JEMT6>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  14. Han R. N., Buch S., Tseu I., Young J., Christie N. A., Frndova H., Lye S. J., Post M., Tanswell A. K. Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen. Pediatr Res. 1996 Jun;39(6):921–929. doi: 10.1203/00006450-199606000-00001. [DOI] [PubMed] [Google Scholar]
  15. Ireys H. T., Anderson G. F., Shaffer T. J., Neff J. M. Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993. Pediatrics. 1997 Aug;100(2 Pt 1):197–204. doi: 10.1542/peds.100.2.197. [DOI] [PubMed] [Google Scholar]
  16. Jobe A. H., Mitchell B. R., Gunkel J. H. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol. 1993 Feb;168(2):508–513. doi: 10.1016/0002-9378(93)90483-y. [DOI] [PubMed] [Google Scholar]
  17. Jobe A. H. Pulmonary surfactant therapy. N Engl J Med. 1993 Mar 25;328(12):861–868. doi: 10.1056/NEJM199303253281208. [DOI] [PubMed] [Google Scholar]
  18. Johnson D. E., Anderson W. R., Burke B. A. Pulmonary neuroendocrine cells in pediatric lung disease: alterations in airway structure in infants with bronchopulmonary dysplasia. Anat Rec. 1993 May;236(1):115-9, 172-3; discussion 120-1. doi: 10.1002/ar.1092360115. [DOI] [PubMed] [Google Scholar]
  19. Kessler D. L., Truog W. E., Murphy J. H., Palmer S., Standaert T. A., Woodrum D. E., Hodson W. A. Experimental hyaline membrane disease in the premature monkey: effects of antenatal dexamethasone. Am Rev Respir Dis. 1982 Jul;126(1):62–69. doi: 10.1164/arrd.1982.126.1.62. [DOI] [PubMed] [Google Scholar]
  20. King K. A., Hua J., Torday J. S., Drazen J. M., Graham S. A., Shipp M. A., Sunday M. E. CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides. J Clin Invest. 1993 May;91(5):1969–1973. doi: 10.1172/JCI116417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Konishi M., Fujiwara T., Naito T., Takeuchi Y., Ogawa Y., Inukai K., Fujimura M., Nakamura H., Hashimoto T. Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA. Eur J Pediatr. 1988 Jan;147(1):20–25. doi: 10.1007/BF00442605. [DOI] [PubMed] [Google Scholar]
  22. Lorenzo A. V. The preterm rabbit: a model for the study of acute and chronic effects of premature birth. Pediatr Res. 1985 Feb;19(2):201–205. doi: 10.1203/00006450-198502000-00011. [DOI] [PubMed] [Google Scholar]
  23. Meredith K. S., deLemos R. A., Coalson J. J., King R. J., Gerstmann D. R., Kumar R., Kuehl T. J., Winter D. C., Taylor A., Clark R. H. Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J Appl Physiol (1985) 1989 May;66(5):2150–2158. doi: 10.1152/jappl.1989.66.5.2150. [DOI] [PubMed] [Google Scholar]
  24. Nilsson R. The artificially ventilated preterm rabbit neonate as experimental model of hyaline membrane disease. Acta Anaesthesiol Scand. 1982 Apr;26(2):89–103. doi: 10.1111/j.1399-6576.1982.tb01733.x. [DOI] [PubMed] [Google Scholar]
  25. Northway W. H., Jr Bronchopulmonary dysplasia: twenty-five years later. Pediatrics. 1992 May;89(5 Pt 1):969–973. [PubMed] [Google Scholar]
  26. Northway W. H., Jr, Rosan R. C., Porter D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357–368. doi: 10.1056/NEJM196702162760701. [DOI] [PubMed] [Google Scholar]
  27. Parker R. A., Lindstrom D. P., Cotton R. B. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics. 1992 Nov;90(5):663–668. [PubMed] [Google Scholar]
  28. Pierce R. A., Albertine K. H., Starcher B. C., Bohnsack J. F., Carlton D. P., Bland R. D. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am J Physiol. 1997 Mar;272(3 Pt 1):L452–L460. doi: 10.1152/ajplung.1997.272.3.L452. [DOI] [PubMed] [Google Scholar]
  29. Sunday M. E., Choi N., Spindel E. R., Chin W. W., Mark E. J. Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas. Hum Pathol. 1991 Oct;22(10):1030–1039. doi: 10.1016/0046-8177(91)90011-d. [DOI] [PubMed] [Google Scholar]
  30. Sunday M. E., Hua J., Dai H. B., Nusrat A., Torday J. S. Bombesin increases fetal lung growth and maturation in utero and in organ culture. Am J Respir Cell Mol Biol. 1990 Sep;3(3):199–205. doi: 10.1165/ajrcmb/3.3.199. [DOI] [PubMed] [Google Scholar]
  31. Sunday M. E., Hua J., Reyes B., Masui H., Torday J. S. Anti-bombesin monoclonal antibodies modulate fetal mouse lung growth and maturation in utero and in organ cultures. Anat Rec. 1993 May;236(1):25–34. doi: 10.1002/ar.1092360107. [DOI] [PubMed] [Google Scholar]
  32. Sunday M. E., Hua J., Torday J. S., Reyes B., Shipp M. A. CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation. J Clin Invest. 1992 Dec;90(6):2517–2525. doi: 10.1172/JCI116145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sunday M. E., Kaplan L. M., Motoyama E., Chin W. W., Spindel E. R. Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest. 1988 Jul;59(1):5–24. [PubMed] [Google Scholar]
  34. Sunday M. E., Willett C. G., Patidar K., Graham S. A. Modulation of oncogene and tumor suppressor gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasia. Lab Invest. 1994 Jun;70(6):875–888. [PubMed] [Google Scholar]
  35. Sunday M. E., Wolfe H. J., Roos B. A., Chin W. W., Spindel E. R. Gastrin-releasing peptide gene expression in developing, hyperplastic, and neoplastic human thyroid C-cells. Endocrinology. 1988 Apr;122(4):1551–1558. doi: 10.1210/endo-122-4-1551. [DOI] [PubMed] [Google Scholar]
  36. Tanswell A. K., Wong L., Possmayer F., Freeman B. A. The preterm rat: a model for studies of acute and chronic neonatal lung disease. Pediatr Res. 1989 May;25(5):525–529. doi: 10.1203/00006450-198905000-00020. [DOI] [PubMed] [Google Scholar]
  37. Veness-Meehan K. A., Moats-Staats B. M., Price W. A., Stiles A. D. Re-emergence of a fetal pattern of insulin-like growth factor expression during hyperoxic rat lung injury. Am J Respir Cell Mol Biol. 1997 May;16(5):538–548. doi: 10.1165/ajrcmb.16.5.9160836. [DOI] [PubMed] [Google Scholar]
  38. Watterberg K. L., Demers L. M., Scott S. M., Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996 Feb;97(2):210–215. [PubMed] [Google Scholar]
  39. deLemos R. A., Coalson J. J. The contribution of experimental models to our understanding of the pathogenesis and treatment of bronchopulmonary dysplasia. Clin Perinatol. 1992 Sep;19(3):521–539. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES